Quantcast

Latest CD20 Stories

2014-12-15 08:30:06

- Anthera to receive up to $48,000,000 plus future product margin on commercial supply HAYWARD, Calif., Dec. 15, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc.

2014-11-26 12:26:43

Health Canada approves GAZYVA((TM)) (obinutuzumab), a medicine that harnesses the body's immune system to kill cancer cells, for patients with chronic lymphocytic leukemia (or CLL)

2014-10-10 12:24:18

Investigators' Oral and Poster Presentations Highlight Canine Lymphoma Antibody Programs KANSAS CITY, Kan., Oct.

2014-06-03 11:18:46

In a head-to-head comparison of two Food and Drug Administration-approved drugs for the treatment of relapsed chronic lymphocytic leukemia (CLL), ibrutinib significantly outperformed ofatumumab as a second-line therapy.

2014-03-27 12:30:38

DUBLIN, Mar.

2014-03-24 20:23:49

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/7dhkqb/investigation) has announced the addition of the "Investigation

2014-03-20 23:01:51

Kanti Rai, MD, and Jacqueline Barrientos, MD, comment on study of new leukemia therapy. Lake Success, NY (PRWEB) March 20, 2014 Two

2013-11-04 09:13:55

Antibodies against the B cell surface protein CD20 have been used successfully to treat B cell-mediated autoimmune diseases and lymphomas.


Word of the Day
lahar
  • A volcanic mudflow.
The word 'lahar' comes from Javanese.
Related